Proscia presents results on AI melanoma diagnostic predictions
Proscia has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for…
November 1, 2022 - 3 minutes
Melanoma
OncoSec slashing staff numbers to prioritize pipeline
OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP).…
October 5, 2022 - 2 minutes
Sponsored
by Biognosys
Using the power of proteomics to predict immunotherapy responses in melanoma and beyond
Next-generation proteomics has a vital role to play in the search for new biomarkers of…
September 27, 2022 - 6 minutes
Swiss scientists reduce resistance of dormant melanoma cells
Small-molecule targeted therapies revolutionized the treatment of metastatic melanoma, provided that the tumors carry the…
September 22, 2022 - 4 minutes
UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines
The London-based startup Ervaxx has launched with a €15.8M Series A round to develop cancer…
November 6, 2019 - 2 minutes
UK Biotech’s Personalized Immunotherapy gets €110M Series B Boost
The UK company Achilles Therapeutics has raised €110M (£100M) to test its personalized cancer cell…
September 3, 2019 - 2 minutes
This Biotech Helps the Immune System to Infiltrate and Destroy Tumors
The Nice-based biotech company Yukin Therapeutics is developing drugs that can work together with checkpoint…
July 5, 2019 - 3 minutes
Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”
Known for curing US President Jimmy Carter’s cancer, Keytruda continues to benefit many other cancer…
July 24, 2018 - 6 minutes
Immunotherapy for Uveal Melanoma is on Track for Early Access in the UK
The UK grants Immunocore access to a fast-track scheme that will make its immunotherapy IMCgp100…
December 12, 2017 - 2 minutes
Biotech Unicorn’s T-Cell Receptor Therapy “Nearly Doubles” Survival in Uveal Melanoma
Immunocore, one of the only three European biotech unicorns, has presented Phase I results for…
November 13, 2017 - 3 minutes
Swiss Researchers Unveil Cancer Immunotherapy Resistance Mechanism
Scientists from the University of Zurich have identified an epigenetic control switch responsible for turning…
July 27, 2017 - 2 minutes
Belgian Biotech Starts Phase Ib with an off-the-shelf mRNA Therapy for Melanoma
eTheRNA has started a Phase Ib trial in patients with melanoma to test a cancer immunotherapy…
June 30, 2017 - 2 minutes
